Article Details
Retrieved on: 2025-07-17 00:14:52
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Targeting CLDN18.2 with monoclonal antibodies (mAbs) and ADCs represents a promising new approach for treating gastric cancer. This published ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here